Viewing Study NCT04343651


Ignite Creation Date: 2025-12-24 @ 11:56 PM
Ignite Modification Date: 2026-01-02 @ 2:10 AM
Study NCT ID: NCT04343651
Status: COMPLETED
Last Update Posted: 2023-01-04
First Post: 2020-03-31
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19
Sponsor: CytoDyn, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Coronavirus Disease 2019 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COVID-19 View